Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
2018 ◽
Vol 68
(8)
◽
pp. 1255-1264
◽
2017 ◽
Vol 23
(3)
◽
pp. S56-S57
◽
2001 ◽
Vol 72
(7)
◽
pp. 1325-1327
◽
2006 ◽
Vol 10
◽
pp. S12
2018 ◽
Vol 32
(3)
◽
pp. 581-597
◽
2017 ◽
Vol 23
(3)
◽
pp. S191-S192
◽
2002 ◽
Vol 21
(5)
◽
pp. 432-434
◽
1988 ◽
Vol 46
(1)
◽
pp. 82-88
◽